Cite

HARVARD Citation

    Wang, M. et al. (n.d.). Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single‐arm, phase 2 study. British journal of haematology. pp. 510-518. [Online]. 
  
Back to record